The role of hereditary spastic paraplegia related genes in multiple sclerosis. A study of disease susceptibility and clinical outcome. por DeLuca, G, Ramagopalan, S, Cader, M, Dyment, D, Herrera, B, Orton, S, Degenhardt, A, Pugliatti, M, Sadovnick, A, Sotgiu, S, Ebers, G

No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis. por Ramagopalan, S, Deluca, G, Morrison, K, Herrera, B, Dyment, D, Orton, S, Bihoreau, M, Degenhardt, A, Pugliatti, M, Sadovnick, A, Sotgiu, S, Ebers, G

Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis. por Ramagopalan, S, Deluca, G, Morrison, K, Herrera, B, Dyment, D, Lincoln, MR, Orton, S, Chao, M, Degenhardt, A, Pugliatti, M, Sadovnick, A, Sotgiu, S, Ebers, G

An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. por DeLuca, G, Ramagopalan, S, Herrera, B, Dyment, D, Lincoln, MR, Montpetit, A, Pugliatti, M, Barnardo, M, Risch, N, Sadovnick, A, Chao, M, Sotgiu, S, Hudson, T, Ebers, G